Efficacy
All of the 176 eligible patients achieved HCR after induction therapy. The median (IQR) time to HCR was 25.0 (21.0–30.0) days in the ATO group and 27.0 (22.0–35.0) days in the RIF group (In all of the 176 patients with a median follow-up of 6 years (95% CI, 5.7–6.3), the 8-year OS was 100%, and the 5- and 8-year EFS were 97.7% (95% CI, 95.3%–100.0%) and 96.6% (95% CI, 93.7%–99.5%), respectively. The 5-year EFS in ATO and RIF groups were both 97.6% (